The company has a growing library of over 5 million de-identified patient samples and clinical data. Culmination Bio works with biotech and life sciences companies to accelerate clinical trials, according to a Nov. 30 Culmination Bio news release.
Culmination Bio spun out from Intermountain Health in March. Merck Global Health Innovation Fund and Amgen Ventures provided the $10 million investment. Culmination Bio will use the funding to develop its Intelligence Platform and fuel its growth.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
